University of Louisville / James Graham Brown Cancer Center Louisville 529-539 — Louisville, Kentucky

University of Louisville / James Graham Brown Cancer Center Louisville 529-539 is a clinical research site located in Louisville, Kentucky, United States 40202.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Louisville

Browse all research sites in Kentucky · View every site in Louisville

• University of Louisville Pediatric Sleep Medicine Center
• University of Louisville 501 E. Broadway, Suite 210
• Norton Audubon Hospital-Norton Cancer Institute - Audubon ( Site 0105)
• University of Louisville Ambulatory Internal Medicine Resident Clinic
• University of Louisville Cancer Center
• University Neurologists PSC Pediatric Division
• University of Louisville 550 Clinic
• Norton Cancer Institute, Audubon Hospital Campus
• Kosair Children's Hospital
• (175) University Lousiville
• Department of Pediatric Critical Care, Kosair Children's Hospital
• Kosair Childrens Hospital

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Louisville / James Graham Brown Cancer Center Louisville 529-539?

University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Louisville / James Graham Brown Cancer Center Louisville 529-539 conducted?

University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).

Is University of Louisville / James Graham Brown Cancer Center Louisville 529-539 accredited by Crixeo Clinical Trials?

University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Louisville / James Graham Brown Cancer Center Louisville 529-539?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.